The closing price of Metlife Inc (NYSE: MET) was $70.98 for the day, down -1.29% from the previous closing price of $71.91. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 4251047 shares were traded.
Ratios:
Our analysis of MET’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.64.
On October 05, 2023, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $71.Deutsche Bank initiated its Hold rating on October 05, 2023, with a $71 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 18 ’24 when PAPPAS BILL sold 27,000 shares for $72.27 per share. The transaction valued at 1,951,325 led to the insider holds 57,768 shares of the business.
TADROS RAMY sold 4,026 shares of MET for $289,479 on Mar 13 ’24. The President, U.S. Business now owns 146,981 shares after completing the transaction at $71.90 per share. On Feb 05 ’24, another insider, Khalaf Michel, who serves as the President & CEO of the company, sold 20,460 shares for $65.95 each. As a result, the insider received 1,349,329 and left with 385,987 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MET now has a Market Capitalization of 51.32B and an Enterprise Value of 67.03B. As of this moment, Metlife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.80, and their Forward P/E ratio for the next fiscal year is 7.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 1.01.
Stock Price History:
Over the past 52 weeks, MET has reached a high of $74.68, while it has fallen to a 52-week low of $48.95. The 50-Day Moving Average of the stock is 70.56, while the 200-Day Moving Average is calculated to be 64.99.
Shares Statistics:
MET traded an average of 3.57M shares per day over the past three months and 2.52M shares per day over the past ten days. A total of 730.82M shares are outstanding, with a floating share count of 604.09M. Insiders hold about 16.45% of the company’s shares, while institutions hold 75.24% stake in the company. Shares short for MET as of Mar 28, 2024 were 7.36M with a Short Ratio of 2.06, compared to 5.33M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.02% and a Short% of Float of 1.23%.
Dividends & Splits
With its trailing 12-month dividend rate of 2.06, MET has a forward annual dividend rate of 2.08. Against a Trailing Annual Dividend Yield of 2.86%, it implies a Forward Annual Dividend Yield of 2.93%. The stock’s 5-year Average Dividend Yield is 3.45. The current Payout Ratio is 113.79% for MET, which recently paid a dividend on Mar 14, 2024 with an ex-dividend date of Feb 05, 2024. Stock splits for the company last occurred on Aug 07, 2017 when the company split stock in a 1122:1000 ratio.
Earnings Estimates
The firm’s stock currently is rated by 11 analysts. On average, analysts expect EPS of $1.87 for the current quarter, with a high estimate of $2.1 and a low estimate of $1.64, while EPS last year was $1.52. The consensus estimate for the next quarter is $2.17, with high estimates of $2.26 and low estimates of $2.05.
Analysts are recommending an EPS of between $8.9 and $8.35 for the fiscal current year, implying an average EPS of $8.69. EPS for the following year is $9.96, with 12 analysts recommending between $10.35 and $9.64.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $17.92B to a low estimate of $17.49B. As of the current estimate, Metlife Inc’s year-ago sales were $16.87B, an estimated increase of 5.10% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $18.27B, a decrease of -1.90% less than the figure of $5.10% in the same quarter last year. There is a high estimate of $19.14B for the next quarter, whereas the lowest estimate is $17.77B.
A total of 8 analysts have provided revenue estimates for MET’s current fiscal year. The highest revenue estimate was $76.1B, while the lowest revenue estimate was $67.02B, resulting in an average revenue estimate of $73.09B. In the same quarter a year ago, actual revenue was $71.72B, up 1.90% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $76.11B in the next fiscal year. The high estimate is $79.19B and the low estimate is $68.77B. The average revenue growth estimate for next year is up 4.10% from the average revenue estimate for this year.
